ARTICLE | Clinical News
TOBI tobramycin 300mg/5mL Nebuliser Solution regulatory update
January 4, 2000 8:00 AM UTC
PGNS said the U.K. Department of Health will use TOBI within the National Health Service system to treat Pseudomonas aeruginosa infections in cystic fibrosis patients. PathoGenesis Ltd. (Hounslow, U.K...